GlassScriptPhysician profile
Bradley E Elrod
NPI 1457337487
$7,825.93
in general payments reported to CMS, 2019-2025
38 companies · $1,466 in 2025
The $1,466 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,763 · 2022: $1,795 · 2023: $1,301 · 2024: $1,501 · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,267.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $734.11 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $684.60 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $639.06 | 2021-2025 | Lifevest |
| Abbott Laboratories | $629.21 | 2021-2025 | Xience Skypoint, Pressurewire, Aveir |
| Boston Scientific Corporation | $595.53 | 2021-2025 | Watchman Flx, Watchman, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $488.13 | 2021-2025 | Verquvo |
| Pfizer INC. | $432.46 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $428.49 | 2021-2025 | Farxiga, Wainua, Andexxa |
| Philips North America LLC | $379.98 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $337.27 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $293.27 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.91 | 2021-2024 | Jardiance |
| Abiomed | $235.46 | 2024-2025 | Impella |
| Novo Nordisk INC | $177.30 | 2024-2025 | Wegovy |
| Esperion Therapeutics, INC. | $160.56 | 2021-2023 | Nexletol |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $157.73 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amarin Pharma, INC. | $137.86 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $120.30 | 2023-2024 | Onpattro |
| Medtronic, INC. | $105.43 | 2021-2025 | Corevalve Evolut R |
| Bayer Healthcare Pharmaceuticals INC. | $101.28 | 2021-2025 | |
| Gilead Sciences, INC. | $85.72 | 2022-2023 | |
| Cardiva Medical, INC. | $82.38 | 2025 | Savvywire, Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals, LTD. | $72.85 | 2022-2023 | Arcalyst |
| Cordis US Corp. | $53.02 | 2024-2025 | Mynxgrip |
| Astellas Pharma US INC | $49.95 | 2021 | |
| Shockwave Medical, INC | $47.56 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $45.46 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $43.19 | 2023-2024 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $35.37 | 2024 | |
| Atricure, INC. | $33.87 | 2024 | |
| Irhythm Technologies, INC. | $29.21 | 2022-2023 | Zio Xt Patch |
| Terumo Medical Corporation | $28.06 | 2025 | Glidewire, Angio-Seal, Metacross Otw |
| Teleflex LLC | $27.33 | 2021-2023 | Vascband |
| Cvrx, INC. | $22.66 | 2025 | Barostim Neo System |
| Glaxosmithkline, LLC. | $18.49 | 2023 | Shingrix, Arexvy |
| Alexion Pharmaceuticals, INC. | $16.05 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.11 | 2021 | |
| Biotronik INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Elrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.